We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTE icon
451
DTE Energy
DTE
$31.1B
$1.9M 0.03%
20,396
-5,198
-20% -$494K
CTMX icon
452
CytomX Therapeutics
CTMX
$705M
$1.88M 0.03%
89,000
-76,000
-46% -$1.58M
MAS icon
453
Masco
MAS
$16B
$1.87M 0.03%
42,580
+6,470
+18% +$263K
ICPT
454
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.87M 0.03%
32,000
+17,000
+113% +$1.07M
CCL icon
455
Carnival Corporation Ltd
CCL
$36.1B
$1.85M 0.03%
27,941
-9,076
-25% -$601K
AKAO
456
DELISTED
Achaogen Inc
AKAO
$1.85M 0.03%
172,555
-10,000
-5% -$126K
IEX icon
457
IDEX
IEX
$16.5B
$1.83M 0.03%
13,895
+10,869
+359% +$1.4M
WELL icon
458
Welltower
WELL
$178B
$1.83M 0.03%
28,713
+555
+2% +$37.3K
MHK icon
459
Mohawk Industries
MHK
$6.9B
$1.83M 0.03%
6,630
+130
+2% +$34.9K
WR
460
DELISTED
Westar Energy Inc
WR
$1.82M 0.03%
+34,562
New +$1.86M
BBY icon
461
Best Buy
BBY
$18B
$1.82M 0.03%
26,578
+4,563
+21% +$270K
JBL icon
462
Jabil
JBL
$32.8B
$1.79M 0.03%
68,301
-10,517
-13% -$298K
BSFT
463
DELISTED
BroadSoft, Inc.
BSFT
$1.79M 0.03%
+32,550
New +$1.77M
KB icon
464
KB Financial Group
KB
$41.2B
$1.78M 0.03%
30,415
+2,000
+7% +$106K
GWW icon
465
W.W. Grainger
GWW
$65.3B
$1.75M 0.03%
7,424
+1,754
+31% +$363K
FPRX
466
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.75M 0.03%
80,000
+30,000
+60% +$965K
STAA icon
467
STAAR Surgical
STAA
$1.16B
$1.75M 0.03%
113,000
NOW icon
468
ServiceNow
NOW
$102B
$1.75M 0.03%
67,045
+7,535
+13% +$187K
MAN icon
469
ManpowerGroup
MAN
$2.39B
$1.75M 0.03%
13,836
+1,721
+14% +$215K
AVB icon
470
AvalonBay Communities
AVB
$27.1B
$1.73M 0.03%
9,670
-1,826
-16% -$331K
PAYX icon
471
Paychex
PAYX
$40.4B
$1.72M 0.03%
25,328
-960
-4% -$63K
AZO icon
472
AutoZone
AZO
$48.3B
$1.7M 0.03%
2,383
-97
-4% -$62K
OMER icon
473
Omeros
OMER
$709M
$1.66M 0.03%
85,370
-8,000
-9% -$150K
BALL icon
474
Ball Corp
BALL
$17B
$1.66M 0.03%
43,767
+765
+2% +$31K
INFO
475
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.65M 0.03%
36,496
+890
+2% +$39.3K

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.